chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a little bit of a rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (a little bit of a rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (a little bit of a rash). At the time of the report, VACCINATION SITE RASH (a little bit of a rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Teeth chattering chills started at 4:45pm lasted about an hour eased with acetominophen and ibuprofin,    nightime sweats and chills (like when a fever breaks) sometime between 2 and 3 am  diarhea started 9:00am on March 4
Lethary; Aches, body aches; soreness at injection site; Chills; Fever; Loose stools; Intense headache; heart raced; got very dizzy; This is a spontaneous report from a contactable consumer, the patient.   A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 12Mar2021 at 09:15 (at 56- years-old) as a single dose for COVID-19 immunisation.  Medical history included unspecified autoimmune conditions. The patient was not aware of having any allergies.  Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole magnesium (PRILOSEC); cyanocobalamin (VITAMIN B-12); calcium (MANUFACTURER UNKNOWN); and colecalciferol (VITAMIN D); all taken for unspecified indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021, the patient felt heart racing and felt dizzy and woozy.  On 13Mar2021, the patient experienced lethargy, aches/body aches, soreness at injection site, chills, fever, loose stools, and intense headache. The clinical course was as follows: immediately after injection, when standing, her heart raced and she got very dizzy, woozy. She sat for additional 40 minutes with water until this somewhat subsided. Then, she had intense headache and loose stools. She had normal fever, aches, chills, body aches and soreness at injection site lasting 48 hours (as reported). Also, lethargy and aches had lasted through Day 5 (as reported). The clinical outcomes of the heart racing, dizzy/woozy, lethargy, aches/body aches, soreness at injection site, chills, fever, loose stools, and intense headache, were recovering.   No follow-up attempts are possible; information about lot number cannot be obtained
Hives began firming on Saturday around 9;10 pm. Skinbegan itching and white fluid filled hives were present across the mid stomach. Upon showing/ bathing they went down and then turned into small pink dots and went away. The next morning they began appearing again with a few on the stomach and on both arms about midway down as well as on neck and behind ears. Steroid lotion was applied after taking antihistamine tablets but this was brief relief. The hives grew to dark pink patches. Prednisone was prescribed and by morning all but a few hives had dissapeared but then by about 1 pm they returned in full force and pink patches covered the right side of the stomach and most of both arms. Legs were on effect a little on Sunday with a couple hives. Face effected on Sunday with hive. Swelling in cheaks on Wednesday despite all other hives nearly dissapearing leaving onkya few small red dots. Today, Thursday hives appear to be gone but cheaksstill pink
Opened vial for ipol is to be stored at 2 Celsius to 8 Celsius.  Temperature excursion for this opened vial at 46.9F converted to Celsius is 8.28 Celsius for 30 minutes while the door was opened to store vaccine shipment in fridge unit.  After the temperature excursion the ipol was administered to the patient.  I was first advised this was not considered out of range temp when converted to Celsius, and that it was ok to use the vaccine, so we used the vial to administer vaccines, then 1 week later we were advised not to use it and to return the vial per DOH.
I felt palpitations around 10-12 minutes after the 1st Pfizer dose was given, and asked the Doctor to take my vital signs. I had an elevated blood pressure reading and the doctor told me stay in the monitoring area. My blood pressure was taken two more times and was increasing each time. My Blood Pressure went up to 168/98, and was told to lay down on the gurney. When I tried to get up from my seat I became extremely dizzy and sat back down. They put me on a wheelchair to transfer me onto the gurney. As I was laying down I experienced waves of diaphoresis, dizziness, headaches. My head felt cloudy and just lightheaded. I was being monitored for 1 1/2 hour before I was picked up to go home. I continued to have these symptoms for the rest of the night along with arm soreness on the site that I was injected on. I did not experience the same symptoms the next day, but I did have a lingering headache till Saturday (12/26/2020) afternoon.
Sudden LOUD ringing in my right ear, followed by SUDDEN loos of hearing.  I can not hear out of my right ear, and the ringing is getting louder each day.
My daughter has not gotten her period for 2 .5 months. Instead she has been spotting brown blood everyday for the past 2.5 months. She has always had regular periods. This is odd for her.
pt recv vax 4AUG95 & 24SEP97 pt broke out everywhere w/chickenpox w/minimal itching;pt was afeb;MD reported that the pt sibling had a similar exp p/vax WAES97101246;
Information has been received from a physician concerning a 17 year old female with no pertinent medical history or drug allergies who on 24-JUL-2008 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (lot # 660553/0070X). Concomitant therapy included ALLEGRA. It was reported that the patient was not feeling well, looked pale, and complained of fatigue and diaphoresis when she came in to get her GARDASIL. Labs done that day after she got GARDASIL came back that she is anemic and the mom was blaming the GARDASIL. On an unspecified date, the patient recovered. The patient was seen by doctor. No product quality complaint was involved. Additional information has been requested.
Pain in left deltoid since vaccine administration. No treatment. No mass, edema, warmth. See attached office note.
Vaccinated 5 days ago and was admitted to the hospital with worsening sob and COVID 19
17JUL91 AM rash began on bilat arms & face & quickly spread to chest & back; Rash continued & inc since; No fever, no anorexia, no fussiness, no itching or discomfort;
No adverse event; Bivalent doses administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient).    Patient ID was reported as 4459093. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant drug was reported. No treatment drug was reported.
99 in armpit. 102 orally. Fever started 1130am. Chills and tired. Low appetite.  Now vomiting 1x just now.   Discussed using APAP/ibuprofun for fever and to rehydrate with pedialyte or watered down gatorade. Not worried about vomiting 1x.    Told mom to go to ER/urgent care if still vomiting tomorrow, acting lethargic, or fever spikes above 104 despite tylenol.
I experienced pain when they injected me with contrast, I felt lightheaded, my blood sugar was 160, my blood pressure also went up and I was cold.
11/16 Cough with fatigue and I decided to get a test PCR and got the results of positive for Covid. 11/18  only called oncologist and PCP to advise on onset of breakthrough Covid. They advised to get the infusion but decided to refuse in hopes to allow others to have it. Also, was currently on chemo therapy and didn't want to chance interfering or making it a exercise in futility. Quarantined and took Aleve to pass this infection. By 11/29 it seem to be over and I did have a little dry cough starting around 12/6 and have right side stabbing pain just below rib cage. 12/10 went to the ER because the pain caused problems for me to breathe. There I got blood work and CAT scan, and they found a blood clot in my lung and kind of water in the lung but not pneumonia. Gave me IV heparin and a antibiotic while on oxygen.
A patient came in to receive the Pfizer booster shot and was administered a diluted version of J&J. The mixture was 1.8ml of saline and approximately 0.3ml was administered to the patient by the RN. After being administered the patient waited 15 minutes at site and there were no signs of adverse reactions noted or stated by the patient.
This is a spontaneous report from a contactable consumer or non-HCP. This consumer reported for a patient.  A patient of unspecified age and gender received bnt162b2 second dose of (BNT162B2; Solution for injection; Lot number: UNKNOWN), via an unspecified route of administration as dose 2, single on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included patient received bnt162b2 first dose of (BNT162B2; Solution for injection; Lot number: UNKNOWN), via an unspecified route of administration as dose 1, single on an unspecified date for covid-19 immunisation. On unspecified date, the patient who was fully vaccinated tested positive. Reporter declined to provide details and will give them the number to call. Lab tests and procedures which included sars-cov-2 test positive on unspecified date. At the time of this report, outcome of events was unknown.  Follow-up attempts completed. No further information expected. Sender's Comments: Linked Report(s): US-PFIZER INC-202101095688 same reporter, drug, AE, different patients.
Slight rash/redness along face and neck and upper torso; hypersensitivity on scalp, face, upper torso (borderline painful tingling on head/face/arms, chest). Even clothing rubbing against the skin "hurts" a little.
This adult patient inadvertently received a dose of pediatric Hep B. Patient has had no reported side effects from medication error. Patient has been notified and will start the adult Hepatitis B series at the recommendation of her hepatologist.
Fever, extreme chills, body aches, headache that last about 12 hours. Some Body aches and slight headache still present after 12 hours.
Pt developed local induration at injection site with 10-15 blisters, varicella appearance.
Information has been received from a male patient who in July 2007, was vaccinated with a dose of zoster vaccine live (Oka/Merck). In September 2007, the patient developed a body rash of red spots from his chest to his feet. His family doctor sent him to a dermatologist. The dermatologist was very concerned and gave him a cream to try to cure the rash. The dermatologist was unable to determine the type because he did not itch. After a month of different creams, he was referred to a dermatology clinic. The clinic doctor determined that it was due to the shingles vaccine. He is using strong steroid cream now. It is six months since the rash started and he is only a little better. He noted that he could not recommend the vaccine to his friends and he wished he had never taken the shot. Additional information has been requested.
Information has been received from a physician concerning a 12 month old white male with a history of hydroceles (surgery in July 2003) who on 15Oct2003 at noon was vaccinated SC in the left arm with a first 0.5ml dose of varicella virus vaccine live. Concomitant vaccination on the same day at noon included a third dose IM in the right arm of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (PREVNAR). There was no other concomitant medication. There was no illness at the time of vaccination. The reporter indicated that three weeks after vaccination the pt developed a varicella like rash. No medical attention was sought. A product quality complaint was not involved. Follow up information from the physician indicated that during the daytime on 02Nov03 the pt's mother noticed red spots on the trunk and extremities. There were a few spots on 02Nov03 and more spots appeared on 02Nov03 through 06Nov03. The pt was not scratching at it. It was noted that the pt received the varicella virus vaccine live 18 days prior to the onset of the rash . A maculopapular rash was seen on the trunk, extremities, axilla, and diaper area. No vesicles were seen. No diagnostic tests were performed. Subsequently, the pt recovered. It was also noted that the pt did not experience any adverse events following prior vaccination. No further information is expected.
The patient received the wrong strength of vaccine as indicated by his age. He received a regular strength FLUZONE QIV when he was indicated for a HIGH DOSE FLUZONE vaccine.
4 days p/vax pt returned to clinic c/o erythema @ inj site; redness itching & low grade fever; dx localized rxn; tx Keflex 4x a day x 10 days;
Vaccination site redness; Vaccination site swollen; Itchy; This is a spontaneous report received from a contactable consumer, the patient. An 81-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) at arm on 16Mar2021 at 13:30 (at the age of 81-year-old) as single dose for COVID-19 immunisation. The patient's medical history included cancer, chronic fatigue and allergy (to unknown substances and corn). The patient's concomitant medications included ADDERAL, thyroid medication (unspecified) for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, about half of upper arm about an inch below where the shot was given turned red and was swollen and itchy and the patient marked the area with pen. On 21Mar2021, the area patient marked with a pen has gotten lighter but the redness has spread outside the marked area and was darker red than the initial redness. The patient did not receive any treatment for events. The clinical outcome of events vaccination site redness, vaccination site swollen and itchy were not resolved. No follow-up attempts are possible. No further information is expected.
Patients mother reports no adverse reactions after vaccine was given. No adverse reaction observed at time of administering vaccine.
Vertigo and buzzing in ears at second dose Rashes all over the body after two weeks of receiving the third dose, Rashes don?t go away with antihistamines and sometimes are painful
Systemic: Allergic: Anaphylaxis-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild
Hospitalization: 9/14/2022 - 9/22/2022 Presentation to the ED: syncopal episode and complaints of urinary frequency and foul-smelling urine over the last several days.  COVID-19 + date: 9/20/22. Treatment: NO SPECIFIC TREATMENT GIVEN. PATIENT DID NOT REQUIRE SUPPLEMENTAL OXYGEN.  Discharge to: Skilled Nursing Facility (SNF).
30' p/inject generalized itching, flushing, heart rate 120, chest tightness, bronchospasms, chills, nausea; pt given DPH in ER place on Pred;
Pfizer-BioNTech COVID-19 Vaccine  dizziness upon receiving vaccine
Hives from head to toe from 10-6 to 10-7. Urgent care gave steroid shot + ADRENALINE shot. BENADRYL - ZANTAC + CLARITIN
has been experiencing extreme dry mouth; booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 74 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Nov2021 (Lot number: FH8028) at the age of 74 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (ongoing); "Enlarged prostate" (ongoing); "Hashimoto's disease" (ongoing); "Blood pressure" (unspecified if ongoing); "Thyroid" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE taken for thyroid disorder (ongoing); TAMSULOSIN taken for prostatomegaly (ongoing); FINASTERIDE AN taken for prostatomegaly (ongoing); LOSARTAN taken for blood pressure abnormal (ongoing); AMLODIPINE BESILATE taken for blood pressure abnormal (ongoing). Vaccination history included: Bnt162b2 (Dose 2, LOT-ER8732), administration date: 31Mar2021, when the patient was 73 years old, for Covid-19 immunization; Bnt162b2 (Dose 1, LOT-EN6202), administration date: 05Mar2021, when the patient was 73 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 15Nov2021, outcome "unknown", described as "booster"; DRY MOUTH (non-serious) with onset Jan2022, outcome "not recovered", described as "has been experiencing extreme dry mouth". The events "booster" and "has been experiencing extreme dry mouth" were evaluated at the physician office visit.
pt brought to the ED with increased confusion and diarrhea x 2 days; productive cough; sinus bradycardia; COVID test positive; admitted to hosp with COVID, acute on chronic renal failure; metabolic encephalopathy; treated with dexamethasone, COVID vitamin cocktail and fluids; pt's condition worsened and he went into asystole; died in the hosp; DNR
On March 3rd, 5 days following vaccination, developed itching and redness at the injection site.   She noticed whelps at the site and an area of bruising.  She notified her physician's office on March 5.  Her physician notified the health department of the call, stating she believed this to be "covid arm".    On March 10, no itching, and redness is nearly resolved.
Bells Palsy on right side of face Valtrex and Prednisone for one week Full recovery 2 weeks later
After leaving the parking lot of the church, I started to feel dizzy, having hotflashes, weak, and I was experiencing fast heartbeat. I pulled over the car, and then I was shacking. I opened the window to get some fresh air, and drunk water. I could not moved or do anything.  I waited in my car for over 20 minutes hoping that I would feel better. I was still feeling weak and shacking. Finally a member of my family came to pick me up. and took me back to the church which was less than one mile.  I explained the situation, they told me that they did not have a doctor on premise and to contact my primary care physician or to go to an emergency care facility. I started to shack less. So  the member of my family took me back home and I just relaxed while I had chills for two hours.
AFTER SECOND SHOT, SHE NOTICED SWELLING AND REDNESS ON YOUR ARM. SHE PUT ICE ON IT, LOOKED LIKE A MOSQUITO LUMP. ITS TENDER, RED AND SWOLLEN. LAST NIGHT SHE FELT A LUMP IN HER NECK. THIS MORNING THE LUMP IS BIGGER. NO TROUBLE BREATHING, SWELLING OF FACE, NO SWELLING OF TONGUE.  IF SHE TOUCHES THE LUMP, ITS PAINFUL. HER ARM IS SENSITIVE TO TOUCH.  Referred patient to PCP .
pericarditis,  headache, nausea, lasting days.  treatment - zofran, colchicine, aspirin, ibuprofen
Fainted twice. During the second faint had a mild shaking (seizure) he was out for about about 10 seconds then came awake. Sweating and hot. He slept for an hour, then was able to stand, and take the stairs up to bed. I'm calling his doctor tomorrow (Monday).
Prolonged low grade fever (9 days) after vaccines given.  Abnormal CBC (WBC = 16.1, 76 lymphocytes, 9 neutrophil, 7 A typ lymph, 1 band).
Headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 09:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 21:00, the patient experienced headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Large local swelling 09/22/2009. Arm had an egg size knot where she received the vaccine, pain down to the elbow and when lifting arm up. The swelling lasted for a week. She also reported an asthma attack on 10/21/09, she did go to the emergency room and was treated with I.A, she was diagnosed with asthma in January. Her previous dose of flu vaccine was in 1989 and at that time her arm was swollen from shoulder to elbow, cold and red. She gets hives after she eats fresh tomatoes.
severe headache at night time after vaccination; exacerbated in the next morning, photophobia, entire body ache, chills, trouble breathing, low grade fever 100.3. On exam BP 150/78 shaking but nonconvulsive, transferred to hospital via ambulance. 1 day admission, spinal tap has r/o meningitis done-normal. Persistent headache few days after discharge 9/19/07-records received for DOS /24-/26/07- DC DX: Probable reaction to meningococcal vaccination. Meningitis has been ruled out. Headache and back pain now stable. Headache and back pain is thought to be due to probable reaction to meningococcal vaccination and probably from the spinal tap also. C/O headache and photophobia. Fever of 103 and sore throat for past 24 hours. Associated neck stiffness and pain.
Booster was delivered to right arm on Monday at 6pm, on Wednesday evening noticed that my BCG (TB vaccine) site - also on the right arm (about 2 inches from covid vaccine site) was red, sore and slightly swollen. Thursday morning it is still red, sore and swollen.  It has not got worse (used pen to outline redness and swelling and in 12 hours it has not increased)
Nerve pain beginning in shoulder joint, tenderness on surface of skin at and around injection site. Referred for physical therapy. Pain increased to elbow, wrist and collarbone. Discontinued physical therapy. Prescribed diclofenac and referred to orthopedic.  Prescribed a course of oral steroids and muscle relaxant, temporarily alleviated for a few days. Pain continues with loss of strength and limited range of motion in left arm.